Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Why? Researchers at Boston Children’s Hospital, led by Byron Brook, PhD, David Dowling, PhD, and Ofer Levy, MD, PhD, found some answers — while providing proof-of-concept of a new system that can ...

Sequencing mRNA vaccines is another important chapter in that story ... “She’s starting to get a really good understanding across all these different model systems, all these different cells, about ...

University of Wisconsin–Madison researchers have developed a promising technique for treating osteoarthritis using ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

Lastly, vaccine hesitancy could plague vaccine-focused firms like Moderna if new concerns about safety issues begin to emerge from the firm's novel mRNA vaccines. We model this into our demand ...

In that respect it follows a similar model to Merck's takeover of AmpTec, another CDMO that uses a PCR platform to make mRNA drugs, for an undisclosed sum last year. Outsourcing services are on of ...

By constructing a mouse model with a complete knockout of the Martre ... and third-generation sequencing to measure mRNA poly(A) tail lengths, the researchers demonstrated that MARTRE proteins ...

Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...